MedAxiom Reports highlight the latest CV industry data, trends and analysis to help hospitals and practices thrive.
Now Available! 2021 Report: CV Data Trends From a Global Pandemic Year
MedAxiom’s ninth annual Cardiovascular Provider Compensation and Production Survey Report – which unveils trends across cardiology, surgery, advanced practice providers and non-clinical compensation – reveals the true impact of the coronavirus pandemic on cardiovascular programs in 2020. In addition to highlighting comparisons between private and integrated models, the report features new panel size metrics for workforce planning. Use this essential strategic planning tool – designed by cardiology, for cardiology – to optimize your organization and transform cardiovascular care in 2022 and beyond.
Coronary computed tomography angiography (CCTA) is one of the most disruptive recent advances in the cardiovascular industry. In order to drive the transformation of cardiovascular care delivery, MedAxiom surveyed its membership to better understand where cardiovascular programs are in their journey of adopting CCTA as well as barriers to adoption. More than 90% of respondents describe CCTA as a valuable cardiovascular imaging modality today and 100% note CCTA as a valuable imaging modality for the future. Regarding CCTA-derived fractional flow reserve (FFRCT), 77% of respondents said FFRCT will have a clinical impact on patient management.
Healthcare organizations face tremendous pressure to decrease expenses while improving quality of care. Although cardiovascular procedure labs have many resources for measuring quality of care, the industry is lacking best practice guidelines and standardization of metrics in terms of operational performance management. In Spring of 2021 MedAxiom interviewed 29 programs, representing more than 200 cardiovascular procedure labs across the U.S., to better understand where innovation opportunities exist in the market to support performance management. Access the report to see the full assessment and explore how to improve data analytics for your cardiovascular procedure labs.
Although the benefits of cardiac rehab (CR) are well documented, only a fraction of eligible patients in the U.S. enroll in a program after a major cardiovascular event or diagnosis. This survey report reveals insights related to CR program offerings, completion rates, staffing, leadership, barriers and more.
National shifts in the healthcare industry, including a move toward value-based reimbursement and provider risk, along with new non-traditional provider competitors, has created an urgent need for transforming the care delivery model. On top of this COVID-19 has shifted organizational priorities and strategies, putting staffing and workforce development in the forefront. MedAxiom surveyed its membership in March 2021 to better understand hiring insights and workforce trends to help CV programs navigate unprecedented times. These survey results helped to shape a new offering – MedAxiom Talent Solutions. Cardiovascular Expertise. Delivered. – that connects healthcare organizations with seasoned cardiovascular experts backed by the entire MedAxiom team.
MedAxiom’s eighth annual Cardiovascular Provider Compensation and Production Survey contains comprehensive data and analysis for cardiovascular organizations facing a new normal amid effects of the COVID-19 pandemic. The data findings reveal important trends across cardiology, surgery, advanced practice providers and non-clinical compensation as many programs are reevaluating compensation models and the definition of work productivity.
In this first annual Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report Ginger Biesbrock, SVP MedAxiom Consulting, outlines current trends in APP roles and responsibilities, productivity, staffing ratios, hours, compensation and much more.
MedAxiom recently surveyed its members to gain insight into the initial impact of COVID-19 on CV organizations across the country. While the situation continues to unfold, a MedAxiom report provides data and insight into how CV organizations have adjusted to a new normal and what actions programs need to take now to ensure viability.
The highly sought-after resource for cardiovascular and healthcare decision makers navigating the volume-to-value shift taking place in the industry. It features the latest data, trends, and analysis you can get only from MedAxiom.
Overall total cardiology compensation increased 3 percent year over year, reaching the second highest total since 2012
Electrophysiologists are once again the top earner
Heart failure cardiologist compensation ($441,845 per FTE), reported for the first time, is 10 percent lower than general non-invasive compensation
The income gap between physicians in private vs. integrated groups narrowed to 3.5 percent
There are more cardiologists age 61 and over than ever before (about 1 in 4)
The specificity of this data can’t be found anywhere else in the country. The report shows cardiology-specific compensation and production information drilled down to:
Plus, this exclusive report includes:
An exclusive, curated collection of cardiovascular healthcare news.